Company Filing History:
Years Active: 2019-2025
Title: Tohru Miyazaki: Innovator in Heterocyclic Compounds
Introduction
Tohru Miyazaki is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds. With a total of 14 patents to his name, Miyazaki's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Miyazaki's latest patents focus on heterocyclic compounds that exhibit orexin type 2 receptor agonist activity. These compounds are particularly useful as agents for the prophylaxis or treatment of narcolepsy. The innovative compounds he has developed are represented by specific formulas, which are detailed in the patent specifications.
Career Highlights
Tohru Miyazaki is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work has garnered attention in the pharmaceutical industry, contributing to the understanding and treatment of sleep disorders.
Collaborations
Miyazaki collaborates with notable colleagues, including Yuichi Kajita and Yuhei Miyanohana. These partnerships enhance the research and development process, fostering innovation in the field.
Conclusion
Tohru Miyazaki is a key figure in the development of heterocyclic compounds, with a focus on improving treatments for narcolepsy. His contributions to the pharmaceutical industry are noteworthy and continue to influence medical research.